PT  - JOURNAL ARTICLE
AU  - Matias, I.
AU  - Chen, J.
AU  - De Petrocellis, L.
AU  - Bisogno, T.
AU  - Ligresti, A.
AU  - Fezza, F.
AU  - Krauss, A.H.-P.
AU  - Shi, L.
AU  - Protzman, C. E.
AU  - Li, C.
AU  - Liang, Y.
AU  - Nieves, A. L.
AU  - Kedzie, K. M.
AU  - Burk, R. M.
AU  - Di Marzo, V.
AU  - Woodward, D. F.
TI  - Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
AID  - 10.1124/jpet.103.061705
DP  - 2004 May 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 745--757
VI  - 309
IP  - 2
4099  - http://jpet.aspetjournals.org/content/309/2/745.short
4100  - http://jpet.aspetjournals.org/content/309/2/745.full
SO  - J Pharmacol Exp Ther2004 May 01; 309
AB  - We investigated whether prostaglandin ethanolamides (prostamides) E2, F2α, and D2 exert some of their effects by 1) activating prostanoid receptors either per se or after conversion into the corresponding prostaglandins; 2) interacting with proteins for the inactivation of the endocannabinoid N-arachidonoylethanolamide (AEA), for example fatty acid amide hydrolase (FAAH), thereby enhancing AEA endogenous levels; or 3) activating the vanilloid receptor type-1 (TRPV1). Prostamides potently stimulated cat iris contraction with potency approaching that of the corresponding prostaglandins. However, prostamides D2, E2, and F2α exhibited no meaningful interaction with the cat recombinant FP receptor, nor with human recombinant DP, EP1-4, FP, IP, and TP prostanoid receptors. Prostamide F2α was also very weak or inactive in a panel of bioassays specific for the various prostanoid receptors. None of the prostamides inhibited AEA enzymatic hydrolysis by FAAH in cell homogenates, or AEA cellular uptake in intact cells. Furthermore, less than 3% of the compounds were hydrolyzed to the corresponding prostaglandins when incubated for 4 h with homogenates of rat brain, lung, or liver, and cat iris or ciliary body. Very little temperature-dependent uptake of prostamides was observed after incubation with rat brain synaptosomes or RBL-2H3 cells. We suggest that prostamides' most prominent pharmacological actions are not due to transformation into prostaglandins, activation of prostanoid receptors, enhancement of AEA levels, or gating of TRPV1 receptors, but possibly to interaction with novel receptors that seem to be functional in the cat iris. The American Society for Pharmacology and Experimental Therapeutics